Vincent Chen
Assistant Professor of Internal Medicine
Medical School
[email protected]

Available to mentor
Vincent Chen
Assistant Professor
  • Center Memberships
  • Recent Publications
    • Manage Your Profile
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Precision Health Initiative
    Recent Publications See All Publications
    • Journal Article
      Physical activity, diet, and social determinants of health associate with health related quality of life and fibrosis in MASLD
      Czapla BC, Dalvi A, Hu J, Moran IJ, Wijarnpreecha K, Chen VL. Scientific Reports, 2025 Dec 1; 15 (1): DOI:10.1038/s41598-025-93082-6
      PMID: 40055450
    • Journal Article
      Letter on 'Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort Study'-Authors' Reply.
      Yeo YH, Newsome PN, Li J, Chen VL. Aliment Pharmacol Ther, 2025 Jul 15; DOI:10.1111/apt.70280
      PMID: 40662998
    • Journal Article
      Rurality and Neighborhood Socioeconomic Status are Associated With Overall and Cause-Specific Mortality and Hepatic Decompensation in Type 2 Diabetes
      Chen VL, Tedesco NR, Hu J, Jasty VSJ, Perumalswami PV. American Journal of Medicine, 2025 May 1; 138 (5): 809 - 818.e10. DOI:10.1016/j.amjmed.2025.01.007
      PMID: 39842541
    • Journal Article
      Editorial: Lipidomics in MASLD and MetALD
      Govalan R, Chen VL. Alimentary Pharmacology and Therapeutics, 2025 Apr 1; 61 (8): 1408 - 1409. DOI:10.1111/apt.70047
      PMID: 39991875
    • Journal Article
      Erratum: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance (Hepatology (2025) 81 (312–320) DOI: 10.1097/HEP.0000000000001112)
      Hepatology, 2025 Apr 1; 81 (4): E133 DOI:10.1097/HEP.0000000000001186
      PMID: 39937959
    • Journal Article
      Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States
      Danpanichkul P, Duangsonk K, Kalligeros M, Fallon MB, Vuthithammee C, Pan CW, Saokhieo P, Derrick W, Pang Y, Chen VL, Kim D, Singal AG, Yang JD, Wijarnpreecha K. Alimentary Pharmacology and Therapeutics, 2025 Mar 1; 61 (6): 959 - 970. DOI:10.1111/apt.18473
      PMID: 39757456
    • Journal Article
      Integrating PNPLA3 into clinical risk prediction
      Chen VL, Vespasiani-Gentilucci U. Liver International, 2025 Mar 1; 45 (3): DOI:10.1111/liv.16103
      PMID: 39282715
    • Journal Article
      Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
      Wong YJ, Chen VL, Abdulhamid A, Tosetti G, Navadurong H, Kaewdech A, Cristiu J, Song M, Devan P, Tiong KLA, Neo JE, Prasoppokakorn T, Sripongpun P, Stedman CAM, Treeprasertsuk S, Primignani M, Ngu JH, Abraldes JG. Hepatology (Baltimore, Md.), 2025 Feb 1; 81 (2): 523 - 531. DOI:10.1097/HEP.0000000000000891
      PMID: 38630497